Bristol-Myers Squibb ( (BMY) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bristol-Myers Squibb’s stock is on the rise, primarily driven by ongoing clinical trial adjustments and regulatory consultations, which have led to a consensus rating of Moderate Buy. Additionally, Goldman Sachs has increased its price target to $57, influenced by positive interim data analysis and continued patient enrollment in the ADEPT-2 study.
More about Bristol-Myers Squibb
YTD Price Performance: -8.72%
Average Trading Volume: 15,680,358
Technical Sentiment Signal: Buy
Current Market Cap: $100.1B
For further insights into BMY stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.